Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Suxiao Zhixie Jiaonang (Quick-Acting Antidiarrheal Capsules) is an approved traditional Chinese medicine (TCM) developed and manufactured by Jilin Fukang Pharmaceutical. It is primarily indicated for the treatment of diarrhea, including cases associated with acute enteritis and damp-heat dysentery. The formulation typically consists of herbal extracts such as Sophorae Flavescentis Radix (Ku Shen), Atractylodis Rhizoma (Cang Zhu), and Glycyrrhizae Radix et Rhizoma (Gan Cao). These components work synergistically to clear heat, resolve dampness, and detoxify the gastrointestinal tract. Pharmacologically, the drug exhibits antimicrobial, anti-inflammatory, and antispasmodic properties, helping to regulate intestinal motility and reduce excessive fluid secretion in the gut.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on suxiao zhixie jiaonang.